Guidelines and literature
Neurology
- 2020
Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
de Zwart, P. L., van Dijken, B. R. J., Holtman, G. A., Stormezand, G. N., Dierckx, R., Jan van Laar, P., & van der Hoorn, A. (2020). Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis. J Nucl Med, 61(4), 498-504. doi:10.2967/jnumed.119.233809
- 2019
18 F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis.
Harlos, C., Metser, U., Poon, R., MacCrostie, P., & Mason, W. (2019). (18) F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis. Curr Oncol, 26(4), e458-e465. doi:10.3747/co.26.4583
- 2019
FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis.
Albrecht, F., Ballarini, T., Neumann, J., & Schroeter, M. L. (2019). FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis. Neuroimage Clin, 21, 101594. doi:10.1016/j.nicl.2018.11.004
- 2019
Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson's disease: a systematic review and meta-analysis.
Gu, S. C., Ye, Q., & Yuan, C. X. (2019). Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson's disease: a systematic review and meta-analysis. Rev Neurosci. doi:10.1515/revneuro-2018-0061
- 2019
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
Katsanos, A. H., Alexiou, G. A., Fotopoulos, A. D., Jabbour, P., Kyritsis, A. P., & Sioka, C. (2019). Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis. Clin Nucl Med, 44(11), 864-869. doi:10.1097/rlu.0000000000002654
- 2018
Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance.
Charidimou, A., Farid, K., Tsai, H. H., Tsai, L. K., Yen, R. F., & Baron, J. C. (2018). Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance. J Neurol Neurosurg Psychiatry, 89(4), 410-417. doi:10.1136/jnnp-2017-316851
- 2018
Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.
Li, H., Deng, L., Bai, H. X., Sun, J., Cao, Y., Tao, Y., . . . Yang, L. (2018). Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol, 39(2), 280-288. doi:10.3174/ajnr.A5472
- 2018
Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies.
Martini, A., Dal Lago, D., Edelstyn, N. M. J., Salgarello, M., Lugoboni, F., & Tamburin, S. (2018). Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies. Front Neurol, 9, 1018. doi:10.3389/fneur.2018.01018
- 2018
EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.
Nobili, F., Arbizu, J., Bouwman, F., Drzezga, A., Agosta, F., Nestor, P., . . . Boccardi, M. (2018). European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain (18) F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol, 25(10), 1201-1217. doi:10.1111/ene.13728
- 2018
Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis.
Shea, Y. F., Barker, W., Greig-Gusto, M. T., Loewenstein, D. A., Duara, R., & DeKosky, S. T. (2018). Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis. J Alzheimers Dis, 64(1), 323-335. doi:10.3233/jad-180239
- 2018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. (2018)
Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., . . . Weller, M. (2019). Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 46(3), 540-557. Retrieved from https://doi.org/10.1007/s00259-018-4207-9. doi:10.1007/s00259-018-4207-9
- 2018
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis.
Bauckneht, M., Chincarini, A., De Carli, F., Terzaghi, M., Morbelli, S., Nobili, F., & Arnaldi, D. (2018). Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis. Sleep Med Rev, 41, 266-274. doi:10.1016/j.smrv.2018.04.001
- 2017
Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis.
Charidimou, A., Farid, K., & Baron, J. C. (2017). Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis. Neurology, 89(14), 1490-1498. doi:10.1212/wnl.0000000000004539
- 2017
Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: A systematic review and meta-analysis.
Yang, M., Sun, J., Bai, H. X., Tao, Y., Tang, X., States, L. J., . . . Yang, L. (2017). Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: A systematic review and meta-analysis. Medicine (Baltimore), 96(19), e6676. doi:10.1097/md.0000000000006676
- 2017
Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies.
Pagano, G., Niccolini, F., Fusar-Poli, P., & Politis, M. (2017). Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies. Ann Neurol, 81(2), 171-180. doi:10.1002/ana.24859
- 2017
Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.
Kaasinen, V., & Vahlberg, T. (2017). Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies. Ann Neurol, 82(6), 873-882. doi:10.1002/ana.25103
- 2016
Imaging of neuroinflammation in dementia: a review.
Stefaniak, J., & O'Brien, J. (2016). Imaging of neuroinflammation in dementia: a review. J Neurol Neurosurg Psychiatry, 87(1), 21-28. doi:10.1136/jnnp-2015-311336
- 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., . . . Tonn, J. C. (2016). Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol, 18(9), 1199-1208. doi:10.1093/neuonc/now058
- 2016
SNMMI Procedure Standard-EANM Practice Guideline for Amyloid PET Imaging of the Brain (2016)
Minoshima, S., Drezezga, A. E., Djekidel, M., Lewis, D. H., Mathis, C. A., McConathy, J., . . . Barthel, H. (2016). SNMMI Procedure Standard-EANM Practice Guideline for Amyloid PET Imaging of the Brain [Guidelines]. 1-16. Retrieved from http://s3.amazonaws.com/rdcms-snmmi/files/production/public/ACNM/Documen...
- 2014
(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J. (2014). (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev, 2014(7), Cd010386. doi:10.1002/14651858.CD010386.pub2
- 1 of 2
- next ›